ResearcherCentral South UniversityActive in the last 2 years
Biaoming Xu
Matched on OpenAlex author ID A5011589581. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 3
2023: 2 papers · 2024: none · 2025: 1 paper
Papers 3
- Interferon-α and thymosin-α1 plus tislelizumab enhance CD8+ T cell cytotoxicity toward pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.isci.2025.113053↗
- Exploring the potential of exosomes in diagnosis and drug delivery for pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/ijc.34195↗
- Effect of exosomes as drug carriers in chemotherapy of pancreatic cancer. Co-author DOI 10.11817/j.issn.1672-7347.2023.220439↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Chaohui Zuo · 3 shared papers, 2023–2025 · strength 0.87
- Paper Effect of exosomes as drug carriers in chemotherapy of pancreatic cancer. DOI 10.11817/j.issn.1672-7347.2023.220439↗
- Paper Interferon-α and thymosin-α1 plus tislelizumab enhance CD8+ T cell cytotoxicity toward pancreatic ductal adenocarcinoma. DOI 10.1016/j.isci.2025.113053↗
- Paper Exploring the potential of exosomes in diagnosis and drug delivery for pancreatic ductal adenocarcinoma. DOI 10.1002/ijc.34195↗
- Shun Deng · 1 shared paper, 2025 · strength 0.25
- Wenzhi Tan · 1 shared paper, 2025 · strength 0.25
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.